WESTMINSTER, Colo. (PRWEB) August 15, 2018
Individuals suffering from ringing in the ears now can receive the patented and clinically proven Neuromonics Tinnitus Treatment (NTT) using an iOS-enabled device and cloud-based system.
The proprietary OasisPro system is easy to use and more affordable than other tinnitus treatments, according to Eula Adams, CEO of Neuromonics. The OasisPro deploys the company’s existing technology on a patient’s iPad or iPhone in a clinician’s office, rather than on Neuromonic’s Oasis-specific device. The OasisPro retains all the features and functionality of the Oasis device, says Adams. Neuromonics will continue to sell the existing Oasis device.
The OasisPro uses a proven, effective treatment protocol. Consumers listen to spectrally modified music designed to retrain the brain to ignore the ringing sounds and stop reacting negatively to them. With research and development beginning in the early 1990s, Neuromonics has helped thousands of tinnitus sufferers improve their quality of life and overcome the daily life challenges associated with tinnitus. The NTT uses music – programmed for each patient’s individual audiological profile – to deliver a neural stimulus that targets the brain’s auditory pathways. The NTT targets the neurological processes of tinnitus: its audiological, attention-based and emotional aspects.
“The cloud-based OasisPro treatment represents an excellent opportunity to realize the benefit of the proven Neuromonics Tinnitus Treatment, using a consumer’s own device,” says Adams. “It's as easy as listening to music on your iPhone.” Patients report significant tinnitus relief, improved sleep, relaxation and concentration, he states, “Neuromonics is thrilled to bring this cost-effective solution to the market, and help more tinnitus sufferers find relief.”
More than 50 million people in the United States suffer from the sound of ringing in the ears, when no external sounds are present. Usually brought on by exposure to loud noise, the problem is especially significant in the military, with more than 34 percent of returning veterans from Iraq and Afghanistan suffering from the condition. For many sufferers, the ringing noise causes fatigue, depression, anxiety, and problems with memory and concentration.
Neuromonics, Inc. (http://www.neuromonics.com)
Based in Westminster, Colo., Neuromonics, Inc., manufactures and distributes clinically proven medical devices to treat tinnitus. The patented and clinically proven Neuromonics Oasis™ provides long-term treatment and significant relief for those with severe tinnitus.
With research and development beginning in the early 1990s, Neuromonics has helped thousands of tinnitus sufferers improve their quality of life and overcome the daily life challenges associated with tinnitus. Today, Neuromonics provides its devices to nearly 2,000 hearing professionals on four continents, through direct relationships and reseller partners. Neuromonics news includes segments on national media including “The Doctors” and CNN.